Last viewed:
CTSO
Prices are updated after-hours
CTSO
|
$0.8099
1.53%
15K
|
Health Technology
(0.0% 1d)
(-17.4% 1m)
(-75.0% 1y)
(0.0% 2d)
(-8.0% 3d)
(-11.8% 7d)
(NaN%
volume)
Earnings Calendar: 2024-03-14
Market Cap: $ 43,972,350
http://cytosorbents.com
Sec
Filling
|
Patents
| 153 employees
(US) CytoSorbents Corp. engages in the critical care immunotherapy, investigation, and commercialization of blood purification technology. Its product portfolio include CytoSorb, ContrastSorb XL, HemoDefend, VetResQ, and DrugSorb. The company was founded by Joseph Rubin on April 25, 2002 and is headquartered in Monmouth Junction, NJ.
immunotherapy
add to watch list
Paper trade
email alert is off
Press-releases
STAR-T Pivotal Trial Results to Be Featured as a Late-Breaking Presentation at the 2024 American Association for Thoracic Surgery Annual Meeting
Published: 2024-04-17
(Crawled : 11:00)
- globenewswire.com
CTSO
|
$0.8099
1.53%
15K
|
Health Technology
| -2.48%
| O: -0.99%
H: 0.0%
C: 0.0%
association
presentation
for
meeting
trial
results
Apheresis Market Worth $3.9 billion | MarketsandMarkets™
Published: 2024-04-12
(Crawled : 14:30)
- prnewswire.com
HAE
|
$84.98
0.96%
150K
|
Health Technology
| -2.72%
| O: -0.62%
H: 0.28%
C: -0.88%
BDX
|
$232.09
0.47%
790K
|
Health Technology
| -3.99%
| O: -0.62%
H: 0.37%
C: -1.66%
BAX
|
$39.66
0.23%
1.6M
|
Health Technology
| -6.05%
| O: -0.9%
H: 0.38%
C: -3.38%
CTSO
|
$0.8099
1.53%
15K
|
Health Technology
| -11.84%
| O: -1.64%
H: 7.87%
C: -2.02%
CERS
|
$1.675
-0.3%
370K
|
Health Technology
| -0.88%
| O: 3.24%
H: 12.0%
C: 0.0%
market
Global Continuous Renal Replacement Therapy (CVVH, CVVHDF, CVVHD, SCUF) Industry Research 2024-2033
Published: 2024-03-29
(Crawled : 18:00)
- prnewswire.com
CTSO
|
$0.8099
1.53%
15K
|
Health Technology
| Email alert
Add to watchlist
MDT
|
$79.1
-0.19%
3.4M
|
Health Technology
| Email alert
Add to watchlist
renal
research
global
therapy
CytoSorbents Reports Fourth Quarter and Full Year 2023 Results
Published: 2024-03-14
(Crawled : 21:00)
- globenewswire.com
SNY
|
$46.24
0.96%
1.2M
|
Health Technology
| -5.29%
| O: -0.02%
H: 0.0%
C: 0.0%
CTSO
|
$0.8099
1.53%
15K
|
Health Technology
| -17.75%
| O: -1.02%
H: 0.0%
C: -8.33%
year
results
CytoSorbents to Present at the TD Cowen 44th Annual Health Care Conference
Published: 2024-02-08
(Crawled : 12:00)
- globenewswire.com
CTSO
|
$0.8099
1.53%
15K
|
Health Technology
| -21.79%
| O: -1.96%
H: 6.0%
C: 2.0%
conference
health
care
Groundbreaking Randomized Controlled Trial Reports Excellent Clinical Outcomes Using CytoSorb® Intraoperatively in Heart Transplant Patients
Published: 2024-01-17
(Crawled : 12:30)
- globenewswire.com
CTSO
|
$0.8099
1.53%
15K
|
Health Technology
| -21.02%
| O: 0.99%
H: 1.96%
C: -0.98%
cytosorb
heart
trial
CytoSorbents Provides Update on the STAR-T Trial and Reports Final Independent Data and Safety Monitoring Board Recommendation
Published: 2023-12-28
(Crawled : 12:00)
- globenewswire.com
CTSO
|
$0.8099
1.53%
15K
|
Health Technology
| -51.06%
| O: -33.74%
H: 1.85%
C: 0.46%
update
trial
CytoSorbents Announces Closing of $10.3 Million Registered Direct Offering
Published: 2023-12-13
(Crawled : 14:30)
- globenewswire.com
CTSO
|
$0.8099
1.53%
15K
|
Health Technology
| -44.6%
| O: -2.08%
H: 25.53%
C: 24.11%
direct
offering
CytoSorbents to Report Third Quarter 2023 Operating and Financial Results
Published: 2023-10-27
(Crawled : 11:00)
- globenewswire.com
CTSO
|
$0.8099
1.53%
15K
|
Health Technology
| -51.95%
| O: -1.81%
H: 2.76%
C: -6.13%
report
financial
results
CytoSorbents to Present at the 8th Annual Dawson James Conference
Published: 2023-10-05
(Crawled : 11:00)
- globenewswire.com
CTSO
|
$0.8099
1.53%
15K
|
Health Technology
| -52.8%
| O: 1.18%
H: 0.0%
C: -5.85%
conference
See all
Last 15 days Sec forms
File Id
Form
Published Date
Transaction Date
Direction
Code
Amount Transacted
Owned Amount
0001104659-24-043796
4
2024-04-05
2024-04-02
Buy
A
22000
22000
0001104659-24-043795
4
2024-04-05
2024-04-02
Buy
A
86000
86000
0001104659-24-043795
4
2024-04-05
2024-04-02
Buy
A
61000
409433
0001104659-24-043794
4
2024-04-05
2024-04-02
Buy
A
22000
22000
0001104659-24-043793
4
2024-04-05
2024-04-02
Buy
A
87000
87000
0001104659-24-043793
4
2024-04-05
2024-04-02
Buy
A
65000
532941
0001104659-24-043792
4
2024-04-05
2024-04-02
Buy
A
44000
44000